Niklas Larsson

Company: AstraZeneca

Job title: Principal Scientist

Seminars:

Discovery of Clinical Candidate AZD5462, an Allosteric Oral Small Molecule Agonist for the Treatment of Heart Failure 9:30 am

Reviewing the optimization of small molecule agonists of the Relaxin Family Peptide Receptor (RXFP1) resulting in discovery of AZD5462 Exploring mechanism of action and signaling in vitro and in vivo Demonstrating the efficacy of AZD5462 in non-human primatesRead more

day: Day Two AM